Heparin cofactor II in diabetic patients
- 1 April 1994
- journal article
- research article
- Published by Wolters Kluwer Health in Blood Coagulation & Fibrinolysis
- Vol. 5 (2) , 201-204
- https://doi.org/10.1097/00001721-199404000-00007
Abstract
Levels of heparin cofactor II (HCII) activity and antigen and electrophoretic pattern were studied both in normal subjects and in type I diabetic patients with high and normal levels of glycosylated haemoglobin. There was a significant reduction in HCII activity (83 ± 7%) in patients with high levels of glycosylated haemoglobin compared with controls (95 ± 17%; P < 0.001). However, plasma HCII antigen levels were not decreased in these patients.Keywords
This publication has 0 references indexed in Scilit: